66-22-8 |
2,4-Dihydroxypyrimidine |
2,4(1H,3H)-Pyrimidinedione |
Pyrod |
2,4-Pyrimidinediol |
2,4-Dioxopyrimidine |
pyrimidine-2,4(1H,3H)-dione |
pyrimidine-2,4-diol |
Hybar X |
2,4-Pyrimidinedione |
Pirod |
51953-14-1 |
1H-Pyrimidine-2,4-dione |
RU 12709 |
Uracil [USAN] |
Urazil |
Ura |
CCRIS 3077 |
CHEBI:17568 |
NSC 3970 |
NSC-3970 |
AI3-25470 |
MFCD00006016 |
Uracyl |
2-Hydroxy-4(3H)-pyrimidinone |
SQ 6201 |
SQ 7726 |
SQ 8493 |
SQ-6201 |
SQ-7726 |
SQ-8493 |
4-Hydroxyuracil |
1,2,3,4-tetrahydropyrimidine-2,4-dione |
BMS 205603-01 |
BMS-205603-01 |
UNII-56HH86ZVCT |
EINECS 200-621-9 |
56HH86ZVCT |
Lamivudine impurity e |
2-Hydroxy-4(1H)-pyrimidinone |
DTXSID4021424 |
Uracil (8CI) |
NSC3970 |
Uracil [USAN:JAN] |
Lamivudine impurity e rs |
144104-68-7 |
URACIL-5-D1 |
URACIL-6-D1 |
DTXCID101424 |
4-Hydroxy-2(1H)-pyrimidinone |
Fluorouracil specified compound c |
NCGC00181030-01 |
URACIL (USP-RS) |
URACIL [USP-RS] |
URACIL (MART.) |
URACIL [MART.] |
24897-50-5 |
CAS-66-22-8 |
CID 5274267 |
24897-51-6 |
LAMIVUDINE IMPURITY F (EP IMPURITY) |
LAMIVUDINE IMPURITY F [EP IMPURITY] |
FLUOROURACIL IMPURITY C (EP IMPURITY) |
FLUOROURACIL IMPURITY C [EP IMPURITY] |
LAMIVUDINE IMPURITY E (USP IMPURITY) |
LAMIVUDINE IMPURITY E [USP IMPURITY] |
66255-05-8 |
FLUOROURACIL SPECIFIED COMPOUND C (USP IMPURITY) |
FLUOROURACIL SPECIFIED COMPOUND C [USP IMPURITY] |
Uracilo |
Xyfid |
Uracil topical |
8h-uracil |
hydroxypyrimidinone |
24-Dioxopyrimidine |
2,4-pirimidinediol |
2 4-Pyrimidinediol |
2,6-Dioxypyrimidin |
Uracil,(S) |
2,4-pirimidinediona |
2 4-Pyrimidinedione |
2,4-Dioxopirimidine |
2,4-Dioxypyrimidine |
2,4(1H,3H)-Pyrimidinedione (9CI) |
pyrimidine-2,4-dione |
24-Dihydroxypyrimidine |
2, 4-Dioxopyrimidine |
Fluorouracil Impurity C |
Uracil, 99% |
1ui0 |
Uracil (JAN/USAN) |
2,3H)-Pyrimidinedione |
2,4-Dihidroxipirimidine |
2,6-Dihydroxypyrimidine |
URACIL [INCI] |
URACIL [JAN] |
URACIL [WHO-DD] |
URACIL [MI] |
bmse000187 |
bmse000940 |
CHEMBL566 |
D0Y0DG |
Epitope ID:120356 |
NCIMech_000782 |
SCHEMBL8235 |
Uracil, >=99.0% |
MLS001304993 |
GTPL4560 |
2,4-(1h,3h)-pyrimidinedione |
2-hydroxy-4-(1H)-pyrimidione |
2-hydroxy-4-(3H)-pyrimidione |
4-hydroxy-2-(1H)-pyrimidione |
1H-pyrimidine-2,4-dione;Uracil |
Uracil, >=99.0% (T) |
2,4 (1h, 3h)-pirimidinaediona |
HMS2234E19 |
HMS3264C13 |
HMS3373E18 |
HMS3652N05 |
Pharmakon1600-01502345 |
BCP26546 |
HY-I0960 |
NSC29742 |
Tox21_112680 |
Tox21_201023 |
BDBM50549809 |
CCG-35866 |
NSC-29742 |
NSC759649 |
s4177 |
STK301734 |
STL124066 |
AKOS000119989 |
AKOS002303991 |
Tox21_112680_1 |
4(3H)-Pyrimidinone,2-hydroxy-(9ci) |
AM83913 |
CCG-213042 |
CS-T-46139 |
CS-W020104 |
DB03419 |
LS-7748 |
NSC-759649 |
PS-5279 |
SB55489 |
SB55884 |
NCGC00181030-02 |
NCGC00247663-01 |
NCGC00258576-01 |
Uracil, Vetec(TM) reagent grade, 98% |
NCI60_003718 |
Pyrimidine-2,4(1H,3H)-dione (Uracil) |
SMR000752912 |
SY008943 |
Uracil 1000 microg/mL in Methanol:Water |
BB 0242167 |
FT-0609769 |
FT-0694063 |
FT-0695907 |
FT-0695908 |
FT-0773727 |
SW220239-1 |
U0013 |
EN300-17138 |
Uracil, suitable for cell culture, BioReagent |
C00106 |
D00027 |
AB00171810_03 |
AB00171810_04 |
AB00918623-05 |
A835376 |
AC-907/30002021 |
Q182990 |
Z56889474 |
F1796-0008 |
E2FC11E5-1887-46DF-B415-82313CE9B2BD |
Uracil, United States Pharmacopeia (USP) Reference Standard |
Fluorouracil impurity C, European Pharmacopoeia (EP) Reference Standard |
InChI=1/C4H4N2O2/c7-3-1-2-5-4(8)6-3/h1-2H,(H2,5,6,7,8 |
Uracil, Pharmaceutical Secondary Standard; Certified Reference Material |
There are more than 10 synonyms. If you wish to see them all click here.
|